- Who we are
-
Capabilities
- Arbitration
- Banking and Finance
- Board Advisory
- Class Actions
- Competition
- Corporate Commercial
-
Employment and Labour
- Diversity and Discrimination
- Employment Contracts, Policies and Procedures
- Employment Disputes
- Executive Remuneration, Governance, Performance and Termination
- Labour Strategies, Industrial Relations and Trade Unions
- Workplace Health and Safety
- Workplace Investigations
- Team Moves and Injunctions
- Training
- Energy and Natural Resources
- Environment and Planning
-
Financial Sponsors
- Fund Formation and Management
- Pension and Sovereign Wealth Funds
- Financial Services Regulation and Superannuation
- Joint Ventures
- Public M&A
- Private M&A
- Private Equity
- Venture Capital Markets
- Special Situations Lending and Investing
- Capital Transactions and Funds
- Infrastructure Capital Transactions
- Construction and Infrastructure Projects
- Public Private Partnerships
- Tax
- Government
-
Intellectual Property
- Advertising, Marketing and Trade Promotions
- Commercialisation and Licensing
- Confidential Information
- Copyright and Designs
- Domain Name Disputes
- Franchising
- Geographical Indications
- Intellectual Property and Patent Litigation
- Misleading Conduct and Passing Off
- Patents
- Therapeutic Goods Regulation and Advertising
- Trade Marks and Branding
- Food Law
-
Investigations
- Whistleblowers and Internal Investigations
- Regulatory Investigations
- Antibribery and Corruption
- White Collar Crime and Fraud
- Royal Commissions, Inquiries and Prosecutions
- Reputation Risk Advisory
- Regulatory Compliance and Anti-Money Laundering
- Forensic Technology Investigations
- Ethics and Compliance
- Trade Investigations
- Workplace Investigations
- Litigation
- M&A and Capital Markets
- Papua New Guinea
- Projects and Construction
- Real Estate
- Responsible Business and ESG
- Restructuring, Insolvency and Special Situations
- Tax
- Technology, Media and Telecommunications
- Insights
- People
- Careers
Home
Insights
Insights
Thoughtful perspectives
Discover our latest perspectives on the big issues impacting our clients
article
Extensions of term for patents covering multiple approved pharmaceutical substances clarified
Read More
article
Rocket docket pharma patent litigation taking off in Australia and other emerging trends
Read More
article
Shifting the starting line: regulatory changes to impact Australian pharma patent disputes
Read More